Health & Biotech
Stories by Tim Boreham
Health & Biotech
Dr Boreham’s Crucible: Vitura Health is the tall poppy in a paddock of weed
Experts
CRITERION: It’s a takeover fire sale on the ASX. These companies are on the specials rack
Experts
Dr Boreham’s Crucible: Does Clinuvel’s investor value run deeper than ‘it just makes Scenesse’?
Experts
CRITERION: Hard rock is so passé; it’s brine’s time in the sun, lithium lovers
Experts
CRITERION: The spotlight’s on earnings season and so far these divas have crushed it
Experts
Dr Boreham’s Crucible: Don’t have a heart attack, CSL’s profit-making ability is in the blood
Experts
CRITERION: Dumped these education stocks lately? That’ll lern ya.
Experts
CRITERION: Thinking of risking a finger on a falling knife? Sometimes they come back…
Health & Biotech
Dr Boreham’s Crucible: ResMed holders breathe easy – those fat-busting needles have only hurt a little bit
Experts
CRITERION: When is a disaster not a disaster?
Experts